BAMCO Inc
HZNP

BAMCO Inc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

BAMCO Inc’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-31,999
Closed -$634K – 344
2015
Q3 		$634K Buy
+31,999
New +$1.01M ﹤0.01% 323

Other funds holding HZNP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BAMCO Inc's HZNP Position: Q4 2015 in Review

BAMCO Inc sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2015, closing a stake of 31,999 shares — an estimated $634K sold.

BAMCO Inc first reported a position in HZNP in Q3 2015 and held it in 1 quarter. The position peaked at $634K in Q3 2015. 202 funds tracked by Wall St. Rank hold HZNP as of Q4 2015.

  • BAMCO Inc reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2015 after selling out during the quarter.
  • BAMCO Inc sold 31,999 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2015, an estimated $634K.
  • BAMCO Inc first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 1 quarter.
  • BAMCO Inc's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $634K in Q3 2015.
  • 202 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2015.

Based on BAMCO Inc's 13F filing for Q4 2015, filed 16 Feb 2016.